PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression!

被引:76
作者
Mariotti, Francesca R. [1 ]
Petrini, Stefania [2 ]
Ingegnere, Tiziano [1 ]
Tumino, Nicola [1 ]
Besi, Francesca [1 ]
Scordamaglia, Francesca [3 ]
Munari, Enrico [4 ,5 ]
Pesce, Silvia [6 ]
Marcenaro, Emanuela [6 ,7 ]
Moretta, Alessandro [6 ,7 ]
Vacca, Paola [1 ]
Moretta, Lorenzo [1 ]
机构
[1] IRCSS Bambino Gesu Childrens Hosp, Dept Immunol, Viale S Paolo 15, Rome, Italy
[2] IRCSS Bambino Gesu Childrens Hosp, Confocal Microscopy Core Facil, Res Ctr, Rome, Italy
[3] AO Villa Scassi, Dept Pneumol, Genoa, Italy
[4] Sacro Cuore Don Calabria Hosp, Dept Pathol, Negrar, Italy
[5] Univ Verona, Dept Pathol, AOUI, Verona, Italy
[6] Univ Genoa, Dept Expt Med DIMES, Genoa, Italy
[7] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy
关键词
Natural killer cells; checkpoint inhibitors; PD-1; CD56(dim) CD56(bright); mRNA isoforms; PD-1 cytoplasmic pool; SOLUBLE PD-1; RECEPTORS; PATHWAY;
D O I
10.1080/2162402X.2018.1557030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Under physiological conditions, PD-1/PD-L1 interactions regulate unwanted over-reactions of immune cells and contribute to maintain peripheral tolerance. However, in tumor microenvironment, this interaction may greatly compromise the immune-mediated anti-tumor activity. PD-1(+) NK cells have been detected in high percentage in peripheral blood and ascitic fluid of ovarian carcinoma patients. To acquire information on PD-1 expression and physiology in human NK cells, we analyzed whether PD-1 mRNA and protein are present in resting, surface PD-1(-), NK cells from healthy donors. Both different splicing isoforms of PD-1 mRNA and a cytoplasmic pool of PD-1 protein were detected. Similar results were obtained also from both in vitro-activated and tumor-associated NK cells. PD-1 mRNA and protein were higher in CD56(dim) than in CD56(bright) NK cells. Confocal microscopy analyses revealed that PD-1 protein is present in virtually all NK cells analyzed. The present findings are compatible with a rapid surface expression of PD-1 in NK cells in response to appropriate, still undefined, stimuli.
引用
收藏
页数:10
相关论文
共 30 条
[1]   PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma [J].
Beldi-Ferchiou, Asma ;
Lambert, Marion ;
Dogniaux, Stephanie ;
Vely, Frederic ;
Vivier, Eric ;
Olive, Daniel ;
Dupuy, Stephanie ;
Levasseur, Frank ;
Zucman, David ;
Lebbe, Celeste ;
Sene, Damien ;
Hivroz, Claire ;
Caillat-Zucman, Sophie .
ONCOTARGET, 2016, 7 (45) :72961-72977
[2]   New immunotherapies targeting the PD-1 pathway [J].
Chinai, Jordan M. ;
Janakiram, Murali ;
Chen, Fuxiang ;
Chen, Wantao ;
Kaplan, Mark ;
Zang, Xingxing .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (09) :587-595
[3]   Human natural killer cells:: a unique innate immunoregulatory role for the CD56bright subset [J].
Cooper, MA ;
Fehniger, TA ;
Turner, SC ;
Chen, KS ;
Ghaheri, BA ;
Ghayur, T ;
Carson, WE ;
Caligiuri, MA .
BLOOD, 2001, 97 (10) :3146-3151
[4]   PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance [J].
Dondero, Alessandra ;
Pastorino, Fabio ;
Della Chiesa, Mariella ;
Corrias, Maria Valeria ;
Morandi, Fabio ;
Pistoia, Vito ;
Olive, Daniel ;
Bellora, Francesca ;
Locatelli, Franco ;
Castellano, Aurora ;
Moretta, Lorenzo ;
Moretta, Alessandro ;
Bottino, Cristina ;
Castriconi, Roberta .
ONCOIMMUNOLOGY, 2016, 5 (01)
[5]   Reconstructed Adeno-Associated Virus with the Extracellular Domain of Murine PD-1 Induces Antitumor Immunity [J].
Elhag, Osama A. O. ;
Hu, Xiao-Jing ;
Wen-Ying, Zhang ;
Li, Xiong ;
Yuan, Yong-Ze ;
Deng, Ling-Feng ;
Liu, De-Li ;
Liu, Ying-Le ;
Hui, Geng .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) :4031-4036
[6]   The PD-1 pathway in tolerance and autoimmunity [J].
Francisco, Loise M. ;
Sage, Peter T. ;
Sharpe, Arlene H. .
IMMUNOLOGICAL REVIEWS, 2010, 236 :219-242
[7]   The Broad Spectrum of Human Natural Killer Cell Diversity [J].
Freud, Aharon G. ;
Mundy-Bosse, Bethany L. ;
Yu, Jianhua ;
Caligiuri, Michael A. .
IMMUNITY, 2017, 47 (05) :820-833
[8]   Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy [J].
Goltz, Diane ;
Gevensleben, Heidrun ;
Dietrich, Joern ;
Ellinger, Joerg ;
Landsberg, Jennifer ;
Kristiansen, Glen ;
Dietrich, Dimo .
ONCOIMMUNOLOGY, 2016, 5 (10)
[9]   Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer [J].
He, Jiabei ;
Hu, Ying ;
Hu, Mingming ;
Li, Baolan .
SCIENTIFIC REPORTS, 2015, 5
[10]   Cancer immunotherapies targeting the PD-1 signaling pathway [J].
Iwai, Yoshiko ;
Hamanishi, Junzo ;
Chamoto, Kenji ;
Honjo, Tasuku .
JOURNAL OF BIOMEDICAL SCIENCE, 2017, 24